No Data
No Data
[Brokerage Focus] Everbright Securities maintains a "buy" rating for Meditool (02158), indicating that there is broad growth potential in the HMPS sector.
Jinwu Finance News | Everbright Securities issued research reports, stating that Yidu Tech (02158) FY2024 (12 months ending March 31, 2024) revenue was RMB 807 million, up 0.3% year-on-year. In terms of profitability, the gross margin was 42.1%, up 8.0pct year-on-year; adjusted EBITDA after excluding non-cash items + interest expenses in non-operating items + self-developed large model investment + income tax expenses reached RMB 31 million for the first time in the full year profit; the net loss attributable to the parent company was significantly reduced from RMB 628 million in the same period last year to RMB 195 million. This
The Consensus EPS Estimates For Yidu Tech Inc. (HKG:2158) Just Fell Dramatically
The analysts covering Yidu Tech Inc. (HKG:2158) delivered a dose of negativity to shareholders today, by making a substantial revision to their statutory forecasts for this year. Revenue and earning
Yidu Tech Reports FY Results
Express News | Yidu Tech Announces Annual Results for FY 2024: Existing Business Achieves First Full-Year Profit on Adjusted Ebitda
Yidu Tech Announces Annual Results for FY 2024: Existing Business Achieves First Full-Year Profit on Adjusted EBITDA
Yidu Tech Inc. ("Yidu Tech" or the "Company", together with its subsidiaries and consolidated affiliated entities, the "Group", HKEX: 2158) announced its annual results for the fiscal year ended 31 March 2024 ("FY2024" or the "Reporting Period"). The management provided detailed explanations on the key performance highlights, development strategies, and future outlook. Owing to the Company's "Focus" strategy, Yidu Tech has seen further improvements in operational efficiency, profitability, and business competitiveness.
Understanding the performance of Yidu Tech (02158) in the fiscal year 2024 with one picture.
On June 28th, China's leading AI medical company, Medwish Technology (02158), held its 2024 fiscal year performance conference.
No Data